ondansetron and thiothixene both increase QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias. toremifene. ondansetron and toremifene both increase QTc interval.
Drug interaction overview. Avoid use with other drugs that have potential to prolong QT interval; hydroxychloroquine prolongs QT interval; ventricular
Drugs to Avoid in Patients with Congenital Long QT Syndrome.1. PPIs do not directly cause prolongation of the QT interval, but they have been
ondansetron and solifenacin both increase QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias. sotalol. ondansetron and sotalol both increase QTc interval. Avoid or Use Alternate Drug.
long-term compelling efficacy for patients, and Avoid coadministration of BRAFTOVI with drugs known to prolong QT/QTc interval.
ondansetron and solifenacin both increase QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias. sotalol. ondansetron and sotalol both increase QTc interval. Avoid or Use Alternate Drug.
QT prolongation should be avoided whenever possible in Drugs that prolong the QT interval and other drugs that prolong the QT interval.
Avoid QT prolonging drugs in patients with congenital long QT syndrome. If long term use of two medicines that can prolong the QT interval is deemed.
All patients with long QT syndrome (LQTS) should avoid drugs that prolong the QT interval or that reduce their serum potassium or magnesium levels.
Comments